Skip to content

Investigation of a New 2-piece Ostomy Product in People With an Ileostomy or Colostomy

Investigation of a New 2-piece Ostomy Product in People With an Ileostomy or Colostomy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02362360
Enrollment
52
Registered
2015-02-12
Start date
2015-02-28
Completion date
2015-05-31
Last updated
2016-10-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colostomy, Ileostomy

Keywords

Ostomy

Brief summary

The purpose of this study is to investigate the influence of a new ostomy product on the peristomal fit for people with an ileo- or colostomy.

Interventions

A new 2-piece ostomy appliance developed by Coloplast A/S

DEVICEComparator (Hollister)

Comparator is a Hollister FlexWear baseplate (ileostomy) or a Hollister SoftFlex baseplate (colostomy) both used with a Hollister open bag.

Sponsors

Coloplast A/S
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Have given written informed consent and in DK: signed a letter of authority * Be at least 18 years of age and have full legal capacity * Have had their ileostomy or colostomy for at least 3 months * Able to use a baseplate size 15 to 40 mm * Be able to handle the product themselves * Normally experience faeces under the baseplate at least 3 times during 2 weeks * Currently using a 2-piece flat product with mechanical coupling * Willing to test both the Coloplast test product and the comparator product * Willing to use an open bag size maxi during the investigation * Willing to use Coloplast test product and comparator products without initial use of accessories (except tube paste / belt) * Willing to use at least 1 baseplate every 3rd day during the investigation * Is able to use a custom cut product * Be suitable for participating in the investigation

Exclusion criteria

* Are currently receiving or have within the past 2 months received radio-and/or chemotherapy (low doses chemotherapy are allowed for other indications than cancer) * Are currently receiving or have within the past month received topical steroid treatment in the peristomal skin area (lotion or spray). Systemic steroid (tablet/injection) treatment are allowed * Are pregnant or breastfeeding * Are participating in other interventional clinical investigations or have previously participated in this investigation * Use irrigation during the investigation (flush the intestines with water) * Are currently suffering from peristomal skin problems i.e. bleeding and/or broken skin (assessed by the investigator) * Have a loop ostomy * Have known hypersensitivity towards any of the products used in the investigation

Design outcomes

Primary

MeasureTime frameDescription
Fit to the Peristomal Area, Measured by a 5-point Scale Ranging From Very Poor to Very Good.21 +/- 3 daysSubjects will evaluate the fit to body for each product by answering the question How was the baseplates ability to fit to the body contours in the area around the stoma?. The question is answered with a 5-point scale ranging from very poor to very good.

Countries

Denmark, Germany, Netherlands, Norway

Participant flow

Pre-assignment details

One subject was a screen failure and was not exposed to any of the test products. This subject was excluded from the safety population, which therefore included 52 subjects.

Participants by arm

ArmCount
Overall Study Population
All subjects included in the investigation
52
Total52

Withdrawals & dropouts

PeriodReasonFG000FG001
Period 1Lack of Efficacy10
Period 1Withdrawal by Subject21

Baseline characteristics

CharacteristicOverall Study Population
Age, Continuous70.9 years
STANDARD_DEVIATION 9.5
Sex: Female, Male
Female
11 Participants
Sex: Female, Male
Male
41 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
9 / 5117 / 49
serious
Total, serious adverse events
0 / 513 / 49

Outcome results

Primary

Fit to the Peristomal Area, Measured by a 5-point Scale Ranging From Very Poor to Very Good.

Subjects will evaluate the fit to body for each product by answering the question How was the baseplates ability to fit to the body contours in the area around the stoma?. The question is answered with a 5-point scale ranging from very poor to very good.

Time frame: 21 +/- 3 days

ArmMeasureGroupValue (NUMBER)
Coloplast Test ProductFit to the Peristomal Area, Measured by a 5-point Scale Ranging From Very Poor to Very Good.Good29.4 percentage of subjects answering
Coloplast Test ProductFit to the Peristomal Area, Measured by a 5-point Scale Ranging From Very Poor to Very Good.Poor3.9 percentage of subjects answering
Coloplast Test ProductFit to the Peristomal Area, Measured by a 5-point Scale Ranging From Very Poor to Very Good.Acceptable9.8 percentage of subjects answering
Coloplast Test ProductFit to the Peristomal Area, Measured by a 5-point Scale Ranging From Very Poor to Very Good.Very poor0 percentage of subjects answering
Coloplast Test ProductFit to the Peristomal Area, Measured by a 5-point Scale Ranging From Very Poor to Very Good.Very good56.9 percentage of subjects answering
ComparatorFit to the Peristomal Area, Measured by a 5-point Scale Ranging From Very Poor to Very Good.Very poor0 percentage of subjects answering
ComparatorFit to the Peristomal Area, Measured by a 5-point Scale Ranging From Very Poor to Very Good.Very good10.6 percentage of subjects answering
ComparatorFit to the Peristomal Area, Measured by a 5-point Scale Ranging From Very Poor to Very Good.Good27.7 percentage of subjects answering
ComparatorFit to the Peristomal Area, Measured by a 5-point Scale Ranging From Very Poor to Very Good.Acceptable42.6 percentage of subjects answering
ComparatorFit to the Peristomal Area, Measured by a 5-point Scale Ranging From Very Poor to Very Good.Poor19.1 percentage of subjects answering

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026